OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sigma-1 receptor and seizures
Edijs Vavers, Liga Zvejniece, Maija Dambrova
Pharmacological Research (2023) Vol. 191, pp. 106771-106771
Open Access | Times Cited: 12

Showing 12 citing articles:

Astrocyte-specific activation of sigma-1 receptors in mPFC mediates the faster onset antidepressant effect by inhibiting NF-κB-induced neuroinflammation
Jingya Wang, Peng Ren, Lin-Yu Cui, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 256-274
Closed Access | Times Cited: 7

Current landscape of fecal microbiota transplantation in treating depression
Qi Zhang, Yajun Bi, Boyu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Novel Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2025)
Closed Access

Navigating the future of retinitis pigmentosa treatments: A comprehensive analysis of therapeutic approaches in rd10 mice
Hongli Yang, Hui Zhang, Xiaorong Li
Neurobiology of Disease (2024) Vol. 193, pp. 106436-106436
Open Access | Times Cited: 3

The classical D1 dopamine receptor antagonist SCH23390 is a functional sigma-1 receptor allosteric modulator
Gu-fang Zhang, Kailian Zhu, Qi Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1582-1590
Closed Access | Times Cited: 2

The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors
Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 10, pp. 1480-1491
Open Access | Times Cited: 3

Preclinical efficacy profiles of the sigma‐1 modulator E1R and of fenfluramine in two chronic mouse epilepsy models
Daniel Pérez‐Pérez, Cristina Monío‐Baca, Eva‐Lotta von Rüden, et al.
Epilepsia (2024) Vol. 65, Iss. 8, pp. 2470-2482
Open Access

Exploring the Role of Sigma Receptors in the Treatment of Cancer: A Narrative Review
George Fotakopoulos, Charalabos Gatos, Vasiliki Georgakopoulou, et al.
Cureus (2024)
Open Access

Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders
Mustafa M Shokr, Ghada A. Badawi, Shimaa M. Elshazly, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 47-65
Closed Access

The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0
Carmen Abate, Tangui Maurice
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15868-15868
Open Access | Times Cited: 1

Page 1

Scroll to top